The lncRNA CCAT1 upregulates TGFβR1 via sponging miR-490-3p to promote TGFβ1-induced EMT of ovarian cancer cells
Ovarian cancer is the fifth leading cause of cancer deaths in women worldwide. was reported to play a critical role in cell metastasis of ovarian cancer. However, little is known about the detailed mechanism of how enhances TGFβ1-induced EMT of ovarian cancer cells. We used RT-qPCR to examine the le...
Gespeichert in:
Veröffentlicht in: | Cancer cell international 2018-09, Vol.18 (1), p.145-145, Article 145 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Ovarian cancer is the fifth leading cause of cancer deaths in women worldwide.
was reported to play a critical role in cell metastasis of ovarian cancer. However, little is known about the detailed mechanism of how
enhances TGFβ1-induced EMT of ovarian cancer cells.
We used RT-qPCR to examine the level of
-
-
and
and western blot to detect the protein level of TGFβR1 and EMT-associated markers. We utilized luciferase reporter assay to confirm the direct interaction of
or TGFβ1 with
-
-
. Wound healing and invasion assay were employed to investigate the role of
and
-
-
in the TGFβ1-induced migration and cell invasion of ovarian cancer cells, respectively.
TGFβ1 stimulated the expression of CCAT1. And CC
knockdown decreased cell migration, invasion and EMT-associated markers expression of ovarian cancer cells treated with TGFβ1.
directly targeted and downregulated
-
-
, then increasing TGFβR1 level.
-
-
was shown to regulate cell invasion, migration and EMT markers expression via TGFβR1. In addition, we also observed that
-
-
was essential for TGFβ1-induced tumor cell invasion and migration influenced by
.
level was significantly higher in tumors than adjacent normal tissue, in contrast,
-
-
level was lower in ovarian tumors.
Here, we reveal that
contributes to TGFβ1-induced EMT of ovarian tumor cells through
-
-
/TGFR1 axis. These findings will provide deep insights into the mechanism by which
exerts its oncogenic role in ovarian cancer progression and facilitate developing novel therapeutical therapies for treating ovarian cancer. |
---|---|
ISSN: | 1475-2867 1475-2867 |
DOI: | 10.1186/s12935-018-0604-1 |